What is ARCB's health score?

ARCBEST CORP /DE/ (ARCB) has a TradeApes health score of 48 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ARCB's estimated fair value?

Based on our 5-year discounted cash flow model, ARCBEST CORP /DE/'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ARCB undervalued or overvalued?

Our model currently rates ARCB as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ARCB... Refresh in a moment for the full analysis.

ARCBEST CORP /DE/ (ARCB)

Industrials Overvalued low mixed

$140.75

Updated: 2026-06-03

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

35 Weak

Relative Value

25 Stressed

Capital Allocation

60 Healthy

Risk

60 Healthy

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.